Empowered Funds
ACTU icon

Empowered Funds’s Actuate Therapeutics ACTU Stock Holding History

Empowered Funds’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18K Buy
+23,106
New +$27.8K ﹤0.01% 2510

Other funds holding ACTU

BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Rock Creek Group
Rock Creek Group Washington, District of Columbia $1.04B AUM 6.61% 1-Year Est. Return
SFMG Wealth Advisors
SFMG Wealth Advisors Plano, Texas $1.66B AUM 20.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Empowered Funds's ACTU Position: Q3 2026 in Review

Empowered Funds opened a new position in Actuate Therapeutics (ACTU) in Q3 2026: 23,106 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #2510 among its holdings.

31 funds tracked by Wall St. Rank hold ACTU as of Q3 2026.

  • Empowered Funds held 23,106 shares of Actuate Therapeutics worth $18K as of Q3 2026.
  • Actuate Therapeutics was a new Empowered Funds position in Q3 2026.
  • Actuate Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2510 holding.
  • 31 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.